Product Information

DILTIAZEM 30 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.0499 per EA under NDC 50228048105. Its NADAC has been published 180 times since Mar 15, 2023.

FDA first approved this application on Sep 23, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 30 MG TABLET

Diltiazem hydrochloride
$0.0499per EA

Strength

30 mg/1

NDC

50228048105

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216521

FDA Approved

9/23/2022

TE Code

AB

On Market Since

9/26/2022

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 30 MG TABLET has been published 180 times since Mar 15, 2023, and over the history we have for it it has declined 45.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0499 per EA
All-time high$0.0955 (Apr 10, 2024)
All-time low$0.0495 (Jul 22, 2026)
52-week high$0.0559
52-week low$0.0495
Median price$0.0664
Average price$0.0684
Largest weekly change+56.6% (Aug 21, 2024)
Weeks tracked180
Tracking sinceMar 15, 2023

Price History

1W

+1.0%

1M

-1.8%

3M

-4.1%

6M

-4.7%

1Y

-10.7%

3Y

-38.6%

5Y

N/A

All

-45.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DILTIAZEM 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 30 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.0499 per EA (NDC 50228048105), effective Aug 19, 2026.

How has the price of DILTIAZEM 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 30 MG TABLET has declined 45.7%. It has been tracked across 180 weekly CMS publications since Mar 15, 2023.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 30 MG TABLET?

Since Mar 15, 2023, the NADAC for DILTIAZEM 30 MG TABLET has ranged from a low of $0.0495 (Jul 22, 2026) to a high of $0.0955 (Apr 10, 2024), with a median of $0.0664 per EA.

Are there cheaper alternatives to DILTIAZEM 30 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 30 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DILTIAZEM 30 MG TABLET?

DILTIAZEM 30 MG TABLET (NDC 50228048105) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.